BRETT WNUK: Open Payments
NPI 1174384929 · TEGA CAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,057 in 114 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $322 · 2025 $2,057
Food & beverage: $2,057
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $371 |
| ABBVIE INC. | 22 | $323 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $267 |
| Otsuka America Pharmaceutical, Inc. | 14 | $199 |
| E.R. Squibb & Sons, L.L.C. | 14 | $175 |
| Lundbeck LLC | 9 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $99 |
| Collegium Pharmaceutical, Inc. | 5 | $97 |
| Supernus Pharmaceuticals, Inc. | 3 | $78 |
| Noven Therapeutics, LLC | 3 | $62 |
Products named: Auvelity, REXULTI, VRAYLAR, TRINTELLIX, COBENFY, CAPLYTA, Jornay PM, Qelbree.
Industry payments across SC — which companies pay providers there.
